冷痛療法市場：製品別、用途別、流通チャネル別：世界の機会分析と産業予測、2023年～2032年

冷痛療法市場は、2022年には19億米ドルと評価され、2023年から2032年までのCAGRは5.1％を示し、2032年には30億4,000万米ドルに達すると推定されています。

クライオセラピーとは寒冷療法を意味します。凍結療法には、アイスパック、冷却スプレー、アイスマッサージ、ジャグジー、アイスバスなど、さまざまな方法があります。家庭でのケガの治療に使われる場合、クライオセラピーは、通常、冷凍庫に必要な時まで入れておく氷やジェルパックによる寒冷療法を指します。これらは、痛みや腫れを管理するための、最もシンプルで、長い歴史を持つ治療法のひとつです。

寒冷療法は炎症を抑えるのに役立ちます。急性の怪我や痛みに使うのが最も効果的です。関節や腱の周りの組織の損傷を軽減する速度を遅らせるのに役立ちます。寒冷療法は、痛んだ筋肉組織を麻痺させ、ほとんど麻酔薬のように作用します。また、脳に伝わる痛みのシグナルを遅らせる効果もあります。冷湿布は、標準的な怪我の一般的な家庭での治療法であるRICE（安静、氷、圧迫、挙上）の一部です。

世界の冷痛療法市場の成長を促進する主な要因には、筋骨格系疾患、関節炎、変形性関節症、関節障害などの増加、より洗練された使いやすい冷痛療法製品の開発につながった技術進歩の急増などがあります。さらに、高齢化人口の増加や、疼痛治療薬の長期使用に伴う潜在的な副作用やリスクに対する意識の高まりが、非薬理学的疼痛管理の需要を高め、市場の成長を促進する主な要因となっています。さらに、主要な市場プレイヤーの増加と、彼らが技術的に高度なコールドペインセラピー製品の開発のために採用する戦略は、コールドペインセラピー市場の成長を後押しする主な要因です。

例えば、2023年3月、可動性と疼痛管理のソリューションで業界をリードするアスペン・メディカル・プロダクツ（Aspen Medical Products：Aspen）と、スポーツと傷害回復分野の大手プロバイダーであるNICEリカバリー・システムズ（NICE Recovery Systems：NICE）は、患者と医療専門家により的確な回復と疼痛管理のソリューションを提供することを目的とした戦略的提携を発表しました。このパートナーシップは、NICE社の高度な低温圧迫技術とアスペン社の効果的な装具ソリューションを活用し、手術や怪我から回復した患者に疼痛管理と術後ケアを提供するものです。

しかし、痛みを即座に和らげるために低価格の鎮痛薬が使用されるようになっていることや、有利な償還がないことが、冷痛療法市場の成長を抑制しています。逆に、鎮痛パッチの採用が増加していることから、予測期間中にコールドペインセラピー市場が成長する有利な機会がもたらされると期待されます。

冷痛療法市場は、製品、用途、流通チャネル、地域に区分されます。製品ベースでは、市場はOTC製品と処方製品に二分されます。OTC製品はさらにクリーム、ジェル、パッチ、その他に、処方箋製品は電動機器と非電動機器に細分化されます。用途別では、筋骨格系障害、術後療法、スポーツ傷害、外傷後療法に分類されます。流通チャネル別では、病院薬局、小売薬局、オンライン薬局に区分されます。

地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州地域）、アジア太平洋（中国、日本、オーストラリア、インド、韓国、その他アジア太平洋地域）、ラテンアメリカ（ブラジル、コロンビア、アルゼンチン、その他アジア太平洋地域）、中東アメリカ（GCC、コロンビア、アルゼンチン、その他南米地域）で分析されます。

利害関係者にとっての主なメリット

• 当レポートでは、2022年から2032年にかけての冷痛療法市場分析の市場セグメント、現在の動向、推定・動向、力学を定量的に分析し、一般的な冷痛療法市場機会を特定します。
• 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
• ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの力を強調します。
• コールドペインセラピーの市場セグメンテーションを詳細に分析することで、市場機会を見極めることができます。
• 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
• 市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
• 本レポートには、地域別および世界の冷痛療法市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

その他の購入特典は以下の通りです：

• 四半期ごとの最新情報および*（コーポレートライセンスのみ、表示価格でのご提供となります）
• 購入前または購入後に、ご希望の企業プロファイルを5社追加で無料アップデート。
• 5ユーザー・ライセンスおよびエンタープライズ・ユーザー・ライセンス購入の場合、次期バージョンを無料で提供。
• アナリストによる16時間のサポート*（購入後、レポートのレビューで追加データ要件が見つかった場合、質問や販売後の問い合わせを解決するためにアナリストによる16時間のサポートを受けることができます。）
• 15％の無料カスタマイズ*（レポートの調査範囲またはセグメントがお客様の要件と一致しない場合、15％は3営業日の無料作業に相当します。）
• 5ユーザーライセンスおよびエンタープライズユーザーライセンスの無料データパック。（エクセル版レポート）
• レポートが6～12ヶ月以上前の場合、更新レポートを無料で提供。
• 24時間優先対応*。
• 業界の最新情報とホワイトペーパーを無料で提供
  
• 本レポートのカスタマイズが可能（別途費用とスケジュールがかかります。）
• 規制ガイドライン
• 顧客の関心に応じた追加企業プロファイル
• 国別または地域別の追加分析-市場規模と予測
• 企業プロファイルの拡張リスト
• 過去の市場データ
• 主要プレーヤーの詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場の定義と範囲
• 主な調査結果
  • 影響要因
  • 主な投資機会
• ポーターのファイブフォース分析
• 市場力学
  • 促進要因
    • スポーツ関連傷害の増加。
    • 外科手術件数の増加。
    • 外傷性損傷症例の増加。
  • 抑制要因
    • 疼痛緩和のための低価格鎮痛薬の入手可能性。
  • 機会
    • 筋骨格系疾患の有病率の上昇。

第4章 冷痛療法市場：製品別

• 概要
• OTC製品
  • OTC製品タイプ別冷痛療法市場
• 処方製品
  • 処方製品タイプ別冷痛療法市場

第5章 冷痛療法市場：用途別

• 概要
• 筋骨格系障害
• 術後療法
• スポーツ傷害
• 外傷後療法

第6章 冷痛療法市場：流通チャネル別

• 概要
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 冷痛療法市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他
• ラテンアメリカ
  • ブラジル
  • コロンビア
  • アルゼンチン
  • その他のラテンアメリカ
• 中東・アフリカ
  • Gcc
  • 南アフリカ
  • 北アフリカ
  • その他

第8章 競争情勢

• イントロダクション
• 主要成功戦略
• 主要10社の製品マッピング
• 競合ダッシュボード
• 競合ヒートマップ
• 主要企業のポジショニング、2022年

第9章 企業プロファイル

• Cardinal Health Inc.
• Sanofi
• Medline Industries, LP
• Beiersdorf AG
• ThermoTek Inc
• 3M Company
• Hisamitsu Pharmaceutical Co.,Inc.
• Bruder Healthcare Company LLC
• Ossur
• Romsons Group of Industries Pvt. Ltd.

LIST OF TABLES

• TABLE 01. GLOBAL COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 02. COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY REGION, 2022-2032 ($MILLION)
• TABLE 03. GLOBAL OTC PRODUCTS COLD PAIN THERAPY MARKET, BY TYPE, 2022-2032 ($MILLION)
• TABLE 04. COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY REGION, 2022-2032 ($MILLION)
• TABLE 05. GLOBAL PRESCRIPTION PRODUCTS COLD PAIN THERAPY MARKET, BY TYPE, 2022-2032 ($MILLION)
• TABLE 06. GLOBAL COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 07. COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 08. COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY REGION, 2022-2032 ($MILLION)
• TABLE 09. COLD PAIN THERAPY MARKET FOR SPORTS INJURIES, BY REGION, 2022-2032 ($MILLION)
• TABLE 10. COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY REGION, 2022-2032 ($MILLION)
• TABLE 11. GLOBAL COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 12. COLD PAIN THERAPY MARKET FOR HOSPITALS PHARMACIES, BY REGION, 2022-2032 ($MILLION)
• TABLE 13. COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
• TABLE 14. COLD PAIN THERAPY MARKET FOR ONLINE PHARMACIES, BY REGION, 2022-2032 ($MILLION)
• TABLE 15. COLD PAIN THERAPY MARKET, BY REGION, 2022-2032 ($MILLION)
• TABLE 16. NORTH AMERICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 17. NORTH AMERICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 18. NORTH AMERICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 19. NORTH AMERICA COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 20. U.S. COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 21. U.S. COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 22. U.S. COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 23. CANADA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 24. CANADA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 25. CANADA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 26. MEXICO COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 27. MEXICO COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 28. MEXICO COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 29. EUROPE COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 30. EUROPE COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 31. EUROPE COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 32. EUROPE COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 33. GERMANY COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 34. GERMANY COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 35. GERMANY COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 36. FRANCE COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 37. FRANCE COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 38. FRANCE COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 39. UK COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 40. UK COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 41. UK COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 42. ITALY COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 43. ITALY COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 44. ITALY COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 45. SPAIN COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 46. SPAIN COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 47. SPAIN COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 48. REST OF EUROPE COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 49. REST OF EUROPE COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 50. REST OF EUROPE COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 51. ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 52. ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 53. ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 54. ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 55. JAPAN COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 56. JAPAN COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 57. JAPAN COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 58. CHINA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 59. CHINA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 60. CHINA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 61. INDIA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 62. INDIA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 63. INDIA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 64. AUSTRALIA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 65. AUSTRALIA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 66. AUSTRALIA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 67. SOUTH KOREA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 68. SOUTH KOREA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 69. SOUTH KOREA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 70. REST OF ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 71. REST OF ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 72. REST OF ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 73. LATIN AMERICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 74. LATIN AMERICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 75. LATIN AMERICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 76. LATIN AMERICA COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 77. BRAZIL COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 78. BRAZIL COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 79. BRAZIL COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 80. COLOMBIA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 81. COLOMBIA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 82. COLOMBIA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 83. ARGENTINA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 84. ARGENTINA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 85. ARGENTINA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 86. REST OF LATIN AMERICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 87. REST OF LATIN AMERICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 88. REST OF LATIN AMERICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 89. MIDDLE EAST AND AFRICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 90. MIDDLE EAST AND AFRICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 91. MIDDLE EAST AND AFRICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 92. MIDDLE EAST AND AFRICA COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 93. GCC COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 94. GCC COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 95. GCC COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 96. SOUTH AFRICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 97. SOUTH AFRICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 98. SOUTH AFRICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 99. NORTH AFRICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 100. NORTH AFRICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 101. NORTH AFRICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 102. REST OF MEA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
• TABLE 103. REST OF MEA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 104. REST OF MEA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
• TABLE 105. CARDINAL HEALTH INC.: KEY EXECUTIVES
• TABLE 106. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
• TABLE 107. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
• TABLE 108. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
• TABLE 109. SANOFI: KEY EXECUTIVES
• TABLE 110. SANOFI: COMPANY SNAPSHOT
• TABLE 111. SANOFI: PRODUCT SEGMENTS
• TABLE 112. SANOFI: PRODUCT PORTFOLIO
• TABLE 113. MEDLINE INDUSTRIES, LP: KEY EXECUTIVES
• TABLE 114. MEDLINE INDUSTRIES, LP: COMPANY SNAPSHOT
• TABLE 115. MEDLINE INDUSTRIES, LP: PRODUCT SEGMENTS
• TABLE 116. MEDLINE INDUSTRIES, LP: PRODUCT PORTFOLIO
• TABLE 117. BEIERSDORF AG: KEY EXECUTIVES
• TABLE 118. BEIERSDORF AG: COMPANY SNAPSHOT
• TABLE 119. BEIERSDORF AG: PRODUCT SEGMENTS
• TABLE 120. BEIERSDORF AG: PRODUCT PORTFOLIO
• TABLE 121. THERMOTEK INC: KEY EXECUTIVES
• TABLE 122. THERMOTEK INC: COMPANY SNAPSHOT
• TABLE 123. THERMOTEK INC: PRODUCT SEGMENTS
• TABLE 124. THERMOTEK INC: PRODUCT PORTFOLIO
• TABLE 125. 3M COMPANY: KEY EXECUTIVES
• TABLE 126. 3M COMPANY: COMPANY SNAPSHOT
• TABLE 127. 3M COMPANY: PRODUCT SEGMENTS
• TABLE 128. 3M COMPANY: PRODUCT PORTFOLIO
• TABLE 129. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY EXECUTIVES
• TABLE 130. HISAMITSU PHARMACEUTICAL CO.,INC.: COMPANY SNAPSHOT
• TABLE 131. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT SEGMENTS
• TABLE 132. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT PORTFOLIO
• TABLE 133. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY STRATERGIES
• TABLE 134. BRUDER HEALTHCARE COMPANY LLC: KEY EXECUTIVES
• TABLE 135. BRUDER HEALTHCARE COMPANY LLC: COMPANY SNAPSHOT
• TABLE 136. BRUDER HEALTHCARE COMPANY LLC: PRODUCT SEGMENTS
• TABLE 137. BRUDER HEALTHCARE COMPANY LLC: PRODUCT PORTFOLIO
• TABLE 138. OSSUR: KEY EXECUTIVES
• TABLE 139. OSSUR: COMPANY SNAPSHOT
• TABLE 140. OSSUR: PRODUCT SEGMENTS
• TABLE 141. OSSUR: PRODUCT PORTFOLIO
• TABLE 142. ROMSONS GROUP OF INDUSTRIES PVT. LTD.: KEY EXECUTIVES
• TABLE 143. ROMSONS GROUP OF INDUSTRIES PVT. LTD.: COMPANY SNAPSHOT
• TABLE 144. ROMSONS GROUP OF INDUSTRIES PVT. LTD.: PRODUCT SEGMENTS
• TABLE 145. ROMSONS GROUP OF INDUSTRIES PVT. LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

• FIGURE 01. COLD PAIN THERAPY MARKET, 2022-2032
• FIGURE 02. SEGMENTATION OF COLD PAIN THERAPY MARKET,2022-2032
• FIGURE 03. TOP IMPACTING FACTORS IN COLD PAIN THERAPY MARKET (2022 TO 2032)
• FIGURE 04. TOP INVESTMENT POCKETS IN COLD PAIN THERAPY MARKET (2023-2032)
• FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
• FIGURE 06. LOW THREAT OF NEW ENTRANTS
• FIGURE 07. LOW THREAT OF SUBSTITUTES
• FIGURE 08. LOW INTENSITY OF RIVALRY
• FIGURE 09. LOW BARGAINING POWER OF BUYERS
• FIGURE 10. GLOBAL COLD PAIN THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
• FIGURE 11. COLD PAIN THERAPY MARKET, BY PRODUCT, 2022 AND 2032(%)
• FIGURE 12. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 13. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 14. COLD PAIN THERAPY MARKET, BY APPLICATION, 2022 AND 2032(%)
• FIGURE 15. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 16. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY COUNTRY 2022 AND 2032(%)
• FIGURE 17. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR SPORTS INJURIES, BY COUNTRY 2022 AND 2032(%)
• FIGURE 18. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY COUNTRY 2022 AND 2032(%)
• FIGURE 19. COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 AND 2032(%)
• FIGURE 20. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR HOSPITALS PHARMACIES, BY COUNTRY 2022 AND 2032(%)
• FIGURE 21. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY COUNTRY 2022 AND 2032(%)
• FIGURE 22. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR ONLINE PHARMACIES, BY COUNTRY 2022 AND 2032(%)
• FIGURE 23. COLD PAIN THERAPY MARKET BY REGION, 2022 AND 2032(%)
• FIGURE 24. U.S. COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 25. CANADA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 26. MEXICO COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 27. GERMANY COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 28. FRANCE COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 29. UK COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 30. ITALY COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 31. SPAIN COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 32. REST OF EUROPE COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 33. JAPAN COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 34. CHINA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 35. INDIA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 36. AUSTRALIA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 37. SOUTH KOREA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 38. REST OF ASIA-PACIFIC COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 39. BRAZIL COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 40. COLOMBIA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 41. ARGENTINA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 42. REST OF LATIN AMERICA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 43. GCC COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 44. SOUTH AFRICA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 45. NORTH AFRICA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 46. REST OF MEA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
• FIGURE 47. TOP WINNING STRATEGIES, BY YEAR (2021)
• FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021)
• FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY (2021)
• FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 51. COMPETITIVE DASHBOARD
• FIGURE 52. COMPETITIVE HEATMAP: COLD PAIN THERAPY MARKET
• FIGURE 53. TOP PLAYER POSITIONING, 2022
• FIGURE 54. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 55. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 56. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 57. SANOFI: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 58. SANOFI: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 59. SANOFI: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 60. BEIERSDORF AG: NET SALES, 2020-2022 ($MILLION)
• FIGURE 61. BEIERSDORF AG: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 62. BEIERSDORF AG: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 63. 3M COMPANY: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 64. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 65. 3M COMPANY: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 66. HISAMITSU PHARMACEUTICAL CO.,INC.: NET SALES, 2020-2022 ($MILLION)
• FIGURE 67. OSSUR: NET SALES, 2020-2022 ($MILLION)
• FIGURE 68. OSSUR: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 69. OSSUR: REVENUE SHARE BY REGION, 2022 (%)

The cold pain therapy market was valued at $1.9 billion in 2022 and is estimated to reach $3.04 billion by 2032, exhibiting a CAGR of 5.1%from 2023 to 2032.

Cryotherapy means cold therapy. Cryotherapy can be applied in various ways, including icepacks, coolant sprays, ice massage, and whirlpools, or ice baths. When used to treat injuries at home, cryotherapy refers to cold therapy with ice or gel packs that are usually kept in the freezer until needed. These remain one of the simplest, time-tested remedies for managing pain and swelling.

Cold therapy helps reduce inflammation. It's most helpful when used for acute injuries and pain. It aids in slowing the rate of reducing tissue damage around a joint or tendon. Cold therapy can numb sore muscle tissue, almost acting as an anesthetic. It has the ability to slow down the pain signals that are transmitted to the brain. Cold compresses are part of a common at-home treatment for standard injuries - RICE - Rest, ice, compression, elevation.

Major factors that drive the growth of the global cold pain therapy market include a rise in the number of musculoskeletal disorders, arthritis, osteoarthritis, joint disorders and others, upsurge in technological advancement that have led to the development of more sophisticated and user-friendly cold pain therapy products. Furthermore, the growing aging population and growing awareness of the potential side effects and risks associated with long-term use of pain medications are the major factors that increase the demand for non-pharmacological pain management and hence propel the growth of the market. In addition, the increase in the number of key market players and the strategies they adopt for the development of technologically advanced cold pain therapy products are the major factors that boost the growth of the cold pain therapy market.

For instance, in March 2023, Aspen Medical Products (Aspen), the industry leader in solutions for mobility and pain management, and NICE Recovery Systems (NICE), a leading provider in the sports and injury recovery space, announced a strategic partnership that aims to bring more precise recovery and pain management solutions to patients and medical professionals. The partnership leverages NICE's advanced cold compression technology with Aspen's effective bracing solutions to deliver pain management and post-operative care to patients recovering from surgery or injury.

However, the growing use of low-priced analgesic pills for immediate pain relief and lack of favorable reimbursement restrain the growth of the cold pain therapy market. On the contrary, the increase in the adoption of analgesic patches is expected to provide lucrative opportunities for the cold pain therapy market to grow during the forecast period.

The cold pain therapy market is segmented into product, application, distribution channel, and region. On the basis of product, the market is bifurcated into OTC products and prescription products. The OTC products are further bifurcated into creams, gels, patches and others and the prescription products are sub-segmented into motorized devices and non-motorized devices. On the basis of application, it is segregated into musculoskeletal disorders, post-operative therapies, sport injuries and post-trauma therapy. On the basis of distribution channel, it is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and Latin America (Brazil, Colombia, Argentina, Rest of LA) and Middle East and Africa (GCC, South Africa, North Africa, Rest of MEA)

The major players profiled in the report are Romsons Group of Industries, Cardinal Health Inc, Sanofi, Breg Inc., Medline Industries LP, Ossur, Hisamitsu Pharmaceutical Inc, Beiersdorf AG, 3M and ThermoTek Inc. The key players such as ThermoTek Inc and Hisamitsu Pharmaceutical Inc have adopted expansion as major developmental strategies to improve the product portfolio

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cold pain therapy market analysis from 2022 to 2032 to identify the prevailing cold pain therapy market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cold pain therapy market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cold pain therapy market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.
  
• Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

• OTC Products
  • Type
  • Creams
  • Gels
  • Patches
  • Others
• Prescription Products
  • Type
  • Motorized Devices
  • Non Motorized Devices

By Application

• Musculoskeletal Disorders
• Post-Operative Therapy
• Sports Injuries
• Post-Trauma Therapy

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Colombia
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Gcc
  • South Africa
  • North Africa
  • Rest Of Mea

Key Market Players:

• Sanofi
• Beiersdorf AG
• 3M Company
• Medline Industries, LP
• Ossur
• Romsons Group of Industries Pvt. Ltd.
• Cardinal Health Inc.
• ThermoTek Inc
• Hisamitsu Pharmaceutical Co.,Inc.
• Bruder Healthcare Company LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Increase in the number of sports related injuries.
    • 3.4.1.2. Increase in the number of surgical procedures.
    • 3.4.1.3. Rise in the number of traumatic injury cases.
  • 3.4.2. Restraints
    • 3.4.2.1. Availability of low-priced analgesic pills for pain relief
  • 3.4.3. Opportunities
    • 3.4.3.1. Rise in the prevalence of musculoskeletal disorders.

CHAPTER 4: COLD PAIN THERAPY MARKET, BY PRODUCT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. OTC Products
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. OTC Products Cold Pain Therapy Market by Type
• 4.3. Prescription Products
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
  • 4.3.4. Prescription Products Cold Pain Therapy Market by Type

CHAPTER 5: COLD PAIN THERAPY MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Musculoskeletal Disorders
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Post-Operative Therapy
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Sports Injuries
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Post-Trauma Therapy
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals Pharmacies
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Retail Pharmacies
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Online Pharmacies
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: COLD PAIN THERAPY MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Product
  • 7.2.3. Market size and forecast, by Application
  • 7.2.4. Market size and forecast, by Distribution Channel
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Product
    • 7.2.5.1.2. Market size and forecast, by Application
    • 7.2.5.1.3. Market size and forecast, by Distribution Channel
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Product
    • 7.2.5.2.2. Market size and forecast, by Application
    • 7.2.5.2.3. Market size and forecast, by Distribution Channel
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Product
    • 7.2.5.3.2. Market size and forecast, by Application
    • 7.2.5.3.3. Market size and forecast, by Distribution Channel
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Product
  • 7.3.3. Market size and forecast, by Application
  • 7.3.4. Market size and forecast, by Distribution Channel
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Product
    • 7.3.5.1.2. Market size and forecast, by Application
    • 7.3.5.1.3. Market size and forecast, by Distribution Channel
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Product
    • 7.3.5.2.2. Market size and forecast, by Application
    • 7.3.5.2.3. Market size and forecast, by Distribution Channel
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Product
    • 7.3.5.3.2. Market size and forecast, by Application
    • 7.3.5.3.3. Market size and forecast, by Distribution Channel
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Product
    • 7.3.5.4.2. Market size and forecast, by Application
    • 7.3.5.4.3. Market size and forecast, by Distribution Channel
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Product
    • 7.3.5.5.2. Market size and forecast, by Application
    • 7.3.5.5.3. Market size and forecast, by Distribution Channel
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Product
    • 7.3.5.6.2. Market size and forecast, by Application
    • 7.3.5.6.3. Market size and forecast, by Distribution Channel
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Product
  • 7.4.3. Market size and forecast, by Application
  • 7.4.4. Market size and forecast, by Distribution Channel
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Product
    • 7.4.5.1.2. Market size and forecast, by Application
    • 7.4.5.1.3. Market size and forecast, by Distribution Channel
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Product
    • 7.4.5.2.2. Market size and forecast, by Application
    • 7.4.5.2.3. Market size and forecast, by Distribution Channel
    • 7.4.5.3. India
    • 7.4.5.3.1. Market size and forecast, by Product
    • 7.4.5.3.2. Market size and forecast, by Application
    • 7.4.5.3.3. Market size and forecast, by Distribution Channel
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Market size and forecast, by Product
    • 7.4.5.4.2. Market size and forecast, by Application
    • 7.4.5.4.3. Market size and forecast, by Distribution Channel
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Product
    • 7.4.5.5.2. Market size and forecast, by Application
    • 7.4.5.5.3. Market size and forecast, by Distribution Channel
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Product
    • 7.4.5.6.2. Market size and forecast, by Application
    • 7.4.5.6.3. Market size and forecast, by Distribution Channel
• 7.5. Latin America
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Product
  • 7.5.3. Market size and forecast, by Application
  • 7.5.4. Market size and forecast, by Distribution Channel
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Product
    • 7.5.5.1.2. Market size and forecast, by Application
    • 7.5.5.1.3. Market size and forecast, by Distribution Channel
    • 7.5.5.2. Colombia
    • 7.5.5.2.1. Market size and forecast, by Product
    • 7.5.5.2.2. Market size and forecast, by Application
    • 7.5.5.2.3. Market size and forecast, by Distribution Channel
    • 7.5.5.3. Argentina
    • 7.5.5.3.1. Market size and forecast, by Product
    • 7.5.5.3.2. Market size and forecast, by Application
    • 7.5.5.3.3. Market size and forecast, by Distribution Channel
    • 7.5.5.4. Rest of Latin America
    • 7.5.5.4.1. Market size and forecast, by Product
    • 7.5.5.4.2. Market size and forecast, by Application
    • 7.5.5.4.3. Market size and forecast, by Distribution Channel
• 7.6. Middle East and Africa
  • 7.6.1. Key market trends, growth factors and opportunities
  • 7.6.2. Market size and forecast, by Product
  • 7.6.3. Market size and forecast, by Application
  • 7.6.4. Market size and forecast, by Distribution Channel
  • 7.6.5. Market size and forecast, by country
    • 7.6.5.1. Gcc
    • 7.6.5.1.1. Market size and forecast, by Product
    • 7.6.5.1.2. Market size and forecast, by Application
    • 7.6.5.1.3. Market size and forecast, by Distribution Channel
    • 7.6.5.2. South Africa
    • 7.6.5.2.1. Market size and forecast, by Product
    • 7.6.5.2.2. Market size and forecast, by Application
    • 7.6.5.2.3. Market size and forecast, by Distribution Channel
    • 7.6.5.3. North Africa
    • 7.6.5.3.1. Market size and forecast, by Product
    • 7.6.5.3.2. Market size and forecast, by Application
    • 7.6.5.3.3. Market size and forecast, by Distribution Channel
    • 7.6.5.4. Rest Of Mea
    • 7.6.5.4.1. Market size and forecast, by Product
    • 7.6.5.4.2. Market size and forecast, by Application
    • 7.6.5.4.3. Market size and forecast, by Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Cardinal Health Inc.
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
• 9.2. Sanofi
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
• 9.3. Medline Industries, LP
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
• 9.4. Beiersdorf AG
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. ThermoTek Inc
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
• 9.6. 3M Company
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Business performance
• 9.7. Hisamitsu Pharmaceutical Co.,Inc.
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
  • 9.7.7. Key strategic moves and developments
• 9.8. Bruder Healthcare Company LLC
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
• 9.9. Ossur
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
• 9.10. Romsons Group of Industries Pvt. Ltd.
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio